| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.6B | $4.3B | $3.7B | $1.7B | $1.4B | $0.4B | $0.3B | $0.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.9B | $0.8B | $0.7B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B |
| Operating Income | $0.7B | $0.8B | $0.5B | $0.5B | $0.2B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.4B | $0.4B | $0.2B | $0.3B | $0.2B | $0.0B | $0.1B | $0.0B |
| EPS (Basic) | $2.06 | $2.03 | $1.05 | $2.89 | $1.38 | $0.45 | $0.47 | $0.33 |
| EPS (Diluted) | $2.04 | $2.01 | $1.04 | $2.86 | $1.36 | $0.44 | $0.47 | $0.32 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.1B | $11.8B | $12.0B | $2.9B | $3.6B | $2.4B | $2.2B | $2.1B |
| Current Assets | $1.8B | $1.7B | $1.8B | $1.0B | $0.8B | $0.6B | $0.7B | $0.6B |
| Cash & Equivalents | $0.5B | $0.5B | $0.6B | $0.5B | $0.3B | $0.3B | $0.4B | $0.2B |
| Total Liabilities | $6.1B | $6.1B | $6.5B | $1.6B | $2.5B | $1.3B | $1.3B | $1.2B |
| Current Liabilities | $1.6B | $1.3B | $1.3B | $0.8B | $0.6B | $0.5B | $0.5B | $0.4B |
| Stockholders' Equity | $5.6B | $5.2B | $5.0B | $1.3B | $1.1B | $1.0B | $0.9B | $0.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.9B | $0.5B | $0.5B | $0.3B | $0.3B | $0.3B | $0.1B |
| Investing Cash Flow | $-0.6B | $-0.3B | $-3.1B | $0.1B | $-0.2B | $-0.3B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.3B | $0.2B | $0.2B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.5B | $-0.6B | $2.7B | $-1.3B | $1.0B | $-0.1B | $-0.2B | $-0.1B |